Senate confirms Erica Schwartz as new CDC leader

A year without a Senate-confirmed director at the CDC and almost nobody outside Washington noticed. That tells you something about how far the agency has drifted from the daily concerns of ordinary Americans, but it also tells you the confirmation fight itself was never really about Erica Schwartz. It was about what the CDC became during Covid and whether anyone in charge is willing to say so out loud.

A 51-44 vote with one Democrat crossing over is not a mandate, it's a trench line. Tim Kaine breaking ranks is interesting mostly because it's the exception that proves how locked-in the opposition was. Nobody on that side of the aisle seems to have asked whether the agency's credibility problem might actually need fixing rather than defending. When trust in public health guidance collapsed for millions of people, the answer from Schwartz's opponents was to treat any nominee willing to acknowledge that collapse as some kind of threat.

Confirming a new director doesn't erase the last few years of mixed messaging, shifting guidance, and agencies that acted more like political actors than scientific ones. But it's at least a chance to reset expectations. If Schwartz spends her tenure defending the old playbook instead of rebuilding confidence in straight answers, this vote will have been wasted breath on both sides.

What matters now is whether she treats the public like adults who can handle uncertainty, instead of subjects who need to be managed. That's a low bar. It's also one the CDC hasn't cleared in years.